Abstract
Implant mucositis and peri-implantitis have an infectious etiology. If left untreated the inflammatory responses and the infection will result in loss of alveolar bone around dental implants. Clinically, this is combined with edema and redness of the soft tissues surrounding the implant. The ultimate consequences of implant mucositis and peri-implantitis may be loss of the implant.
Dental implant manufacturers have focused on implant design, ease of placement, esthetics, and new prosthetic components. Enhancement of osseo-integration has been attempted by changing titanium surface structures, titanium purity, and various coatings.
The biofilm structures at titanium dental implants comprise of bacteria that co-aggregate with each other and are difficult to eliminate mainly due to the rough threaded surfaces of oral implants making them difficult to debride. The microbiota initiates a host inflammatory response that in many aspects are similar to what can be seen in periodontitis. The prevalence of peri-implantitis ranges between 15 and 25%. Patients who have lost teeth due to periodontitis may be more prone to peri-implantitis. The susceptibility may be directly associated with a genetically complex predisposing risk.
Recent data suggest that professional mechanical debridement of pockets around implants and the patients’ own ability to keep implants free from bacteria is unpredictable. Professional debridement may be efficacious over shorter time periods and would most likely require intensive supportive therapy. In the event of limited response to nonsurgical mechanical supportive therapy, the adjunct use of local application of a slow-release antimicrobial agent could be considered. Surgical treatment to eliminate soft tissue pocket and attempts to establish hygienic conditions may not be acceptable to the patient in the esthetic areas. In these situations regenerative therapy may be considered.
Antibiotics are commonly used in medicine to treat infections. Restrictive use of antibiotics is a necessity to prevent the occurrence of wide-spread antibiotic resistance. Peri-implantitis is a local infection confined to the area around the affected implant. Therefore, local administration of an antibiotic drug in a high concentration is logical. Several local antibiotic products have been developed and studied extensively. Such local antibiotic drugs have been on the market for some years but due to a variety of factors some of these local antibiotics have been withdrawn from the market or may only be available in some countries. There is a need to develop new methods allowing effective delivery of local antibacterial and anti-inflammatory agents for the treatment of implant infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schroeder A, Pohler O, Sutter F. Tissue reaction to an implant of a titanium hollow cylinder with a titanium surface spray layer SSO. Schweiz Monatsschr Zahnheilkd. 1976;86: 713–27.
Schroeder A, van der Zypen E, Stich H, et al. The reactions of bone, connective tissue, and epithelium to endosteal implants with titanium-sprayed surfaces. J Maxillofac Surg. 1981;9:15–25.
Axelsson P, Lindhe J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. J Clin Periodontol. 1978;5:133–51.
Albrektsson T, Brånemark PI, Hansson HA, et al. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand. 1981;52:155–70.
Vignoletti F, de Sanctis M, Berglundh T, et al. Early healing of implants placed into fresh extraction sockets: an experimental study in the beagle dog. III: soft tissue findings. J Clin Periodontol. 2009;36:1059–66.
Babbush CA. Titanium plasma spray screw implant system for reconstruction of the edentulous mandible. Dent Clin North Am. 1986;30:117–31.
Buser D, Weber HP, Brägger U. The treatment of partially edentulous patients with ITI hollow-screw implants: presurgical evaluation and surgical procedures. Int J Oral Maxillofac Impl. 1990;5:165–75.
Wedgwood D, Jennings KJ, Critchlow HA. Experience with ITI osseointegrated implants at five centres in the UK. Br J Oral Maxillofac Surg. 1992;30:377–81.
Laney WR, Jemt T, Harris D, et al. Osseointegrated implants for single-tooth replacement: progress report from a multicenter prospective study after 3 years. Int J Oral Maxillofac Impl. 1994;9:49–54.
Aglietta M, Siciliano VI, Zwahlen M, et al. A systematic review of the survival and complication rates of implant supported fixed dental prostheses with cantilever extensions after an observation period of at least 5 years. Clin Oral Implants Res. 2009;20:441–51.
Ong CT, Ivanovski S, Needleman IG, et al. Systematic review of implant outcomes in treated periodontitis subjects. J Clin Periodontol. 2008;35:438–62.
Bosker H, Jordan RD, Sindet-Pedersen S, Koole R. The transmandibular implant: a 13-year survey of its use. J Oral Maxillofac Surg. 1991;49:482–92.
Ekfeldt A, Johansson LA, Isaksson S. Implant-supported overdenture therapy: a retrospective study. Int J Prosthodont. 1997;10:366–74.
Brägger U, Aeschlimann S, Bürgin W, et al. Biological and technical complications and failures with fixed partial dentures (FPD) on implants and teeth after four to five years of function. Clin Oral Implants Res. 2001;12:26–34.
Henry PJ, Laney WR, Jemt T. Osseointegrated implants for single-tooth replacement: a prospective 5-year multicenter study. Int J Oral Maxillofac Impl. 1996;11:450–5.
Simonis P, Dufour T, Tenenbaum H. Long-term implant survival and success: a 10–16-year follow-up of non-submerged dental implants. Clin Oral Impl. 2010;21:772–7.
Fransson C, Lekholm U, Jemt T, Berglundh T. Prevalence of subjects with progressive bone loss at implants. Clin Oral Impl Res. 2005;16:440–6.
Roos-Jansåker AM, Lindahl C, Renvert H, et al. Nine- to fourteen-year follow-up of implant treatment. Part II: presence of peri-implant lesions. J Clin Periodontol. 2006;33:290–5.
Koldsland OC, Scheie AA, Aass AM. Prevalence of peri-implantitis related to severity of the disease with different degrees of bone loss. J Periodontol. 2010;81:231–8.
Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. I. Success criteria and epidemiology. Eur J Oral Sci. 1998;106:527–51.
Máximo MB, de Mendonça AC, Alves JF, et al. Peri-implant diseases may be associated with increased time loading and generalized periodontal bone loss: preliminary results. J Oral Implantol. 2008;34:268–73.
Bower RC, Radny NR, Wall CD, Henry PJ. Clinical and microscopic findings in edentulous patients 3 years after incorporation of osseointegrated implant-supported bridgework. J Clin Periodontol. 1989;16:580–7.
Adell R, Lekholm U, Rockler B, et al. Marginal tissue reactions at osseointegrated titanium fixtures (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg. 1986;15:39–52.
van Steenberghe D, Klinge B, Lindén U. Periodontal indices around natural and titanium abutments: a longitudinal multicenter study. J Periodontol. 1993;64:538–41.
Leonhardt Å, Dahlén G, Renvert S. Five year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man. J Periodontol. 2003;74:1415–22.
Harris LG, Richards RG. Staphylococcus aureus adhesion to different treated titanium surfaces. J Mater Sci Mater Med. 2004;15:311–4.
Antoci Jr V, Adams CS, Parvizi J, et al. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res. 2007;461:81–7.
Renvert S, Lindahl C, Renvert H, et al. Clinical and microbiological analysis of subjects treated with Brånemark or AstraTech implants: a 7-year follow-up study. Clin Oral Implants Res. 2008;19:342–7.
Renvert S, Lessem J, Dahlén G, et al. Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol. 2008;79:836–44.
Persson GR, Samuelsson E, Lindahl C, et al. Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II. Microbiological results. J Clin Periodontol. 2010;37:563–73.
Haffajee AD, Socransky SS. Introduction to microbial aspects of periodontal biofilm communities, development and treatment. Periodontol. 2006;42:7–12.
Albrektsson T, Isidor F. Consensus report of session IV. In: Lang NP, Karring T, editors. Proceedings of the First European Workshop on Periodontology. London: Quintessence; 1994. p. 365–9.
Lindhe J, Meyle J, Group D of European Workshop on Periodontology. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35 Suppl 8:282–5.
Gualini F, Berglundh T. Immunohistochemical characteristics of inflammatory lesions at implants. J Clin Periodontol. 2003;30:14–8.
Gristina AG. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res. 1994;298:106–18.
Bullon P, Fioroni M, Goteri G, et al. Immunohistochemical analysis of soft tissues in implants with healthy and peri-implantitis condition, and aggressive periodontitis. Clin Oral Implants Res. 2004;15:553–9.
Page RC, Beck JD. Risk assessment for periodontal diseases. Int Dent J. 1997;47:61–87.
Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol. 2000;71:1699–707.
Papapanou PN, Behle JH, Kebschull M. Subgingival bacterial colonization profiles correlate with gingival tissue gene expression. BMC Microbiol. 2009;18(9):221.
Kronström M, Svensson B, Erickson E, et al. Humoral immunity host factors in subjects with failing or successful titanium dental implants. J Clin Periodontol. 2000;27:875–82.
Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43:5721–32.
Paster BJ, Olsen I, Aas JA, et al. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol. 2006;42:80–7.
Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192: 5002–17.
Pontoriero R, Tonelli MP, Carnevale G. Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Impl Res. 1994;5:254–9.
Augthun M, Conrads B. Microbial findings of deep peri-implant bone defects. Int J Oral and Maxillofac Impl. 1997;12:106–12.
Salcetti JM, Moriarty JD, Cooper LF. The clinical, microbial and host response characteristics of the failing implant. Int J Oral Maxillofac Impl. 1997;12:32–42.
Leonhardt A, Renvert S, Dahlén G. Microbial findings at failing implants. Clin Oral Implants Res. 1999;10:339–45.
Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: a review of the literature. Clin Oral Impl Res. 2002;13:1–19.
Quirynen M, Vogels R, Peeters W, et al. Dynamics of initial subgingival colonization of “pristine” peri-implant pockets. Clin Oral Implants Res. 2006;17:25–37.
Mombelli A. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol. 2002;28:177–89.
Renvert S, Roos-Jansåker AM, Lindahl C, et al. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin Oral Implants Res. 2007;18:509–16.
Stoodley P, Kathju S, Hu FZ, et al. Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin Orthop Relat Res. 2005;437:31–40.
Shibli JA, Melo L, Ferrari DS, et al. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Impl. 2008;19:975–82.
De Boever AL, De Boever JA. Early colonization of non-submerged dental implants in patients with a history of advanced aggressive periodontitis. Clin Oral Implants Res. 2006;17:8–17.
Fürst MM, Salvi GE, Lang NP, Persson GR. Bacterial colonization immediately after installation on oral titanium implants. Clin Oral Implants Res. 2007;18:501–8.
Salvi GE, Fürst MM, Lang NP, et al. One-year bacterial colonization patterns of Staphylococcus aureus and other bacteria at implants and adjacent teeth. Clin Oral Implants Res. 2008; 19:242–8.
Harris LG, Mead L, Müller-Oberländer E, Richards RG. Bacteria and cell cytocompatibility studies on coated medical grade titanium surfaces. J Biomed Mater Res A. 2006;78:50–8.
Khoo X, O’Toole GA, Nair SA et al. Staphylococcus aureus resistance on titanium coated with multivalent PEGylated-peptides. Biomaterials. 2010;31:9285–92.
Cosyn J, Van Aelst L, Collaert B, Persson GR, De Bruyn H. The peri-implant sulcus compared with internal implant and suprastructure components: a microbiological analysis. Clin Implant Dent Relat Res. 2011;13:286–95.
Elter C, Heuer W, Demling A, et al. Supra- and subgingival biofilm formation on implant abutments with different surface characteristics. Int J Oral Maxillofac Impl. 2008;23:327–34.
Esposito M, Hirsch J, Lekholm U, Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: a review of the literature. Int J Oral Maxillofac Impl. 1999;14:473–90.
Grusovin MG, Coulthard P, Worthington HV et al. Interventions for replacing missing teeth: maintaining and recovering soft tissue health around dental implants. Cochrane Database Syst Rev. 2010;8:CD003069.
Máximo MB, de Mendonça AC, Renata Santos V, et al. Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies. Clin Oral Implants Res. 2009;20:99–108.
Renvert S, Samuelsson E, Lindahl C. Mechanical non-surgical treatment of peri-implantitis: a double-blind randomized longitudinal clinical study. I: clinical results. J Clin Periodontol. 2009;36:604–9.
Schwarz F, Bieling K, Nuesry E, et al. Clinical and histological healing pattern of peri-implantitis lesions following non-surgical treatment with an Er:YAG laser. Lasers Surg Med. 2006;38:663–71.
Esposito M, Cannizarro G, Bozzoli P, et al. Effectiveness of prophylactic antibiotics at placement of dental implants: a pragmatic multicentre placebo-controlled randomised clinical trial. Eur J Oral Implantol. 2010;3:135–43.
Esposito M, Worthington HV, Loli V, Grusovin P. Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications. Cochrane Database Syst Rev. 2010;7:CD004152.
Abu-Ta’a M, Quirynen M, Teughels W, van Steenberghe D. Asepsis during periodontal surgery involving oral implants and the usefulness of peri-operative antibiotics: a prospective, randomized, controlled clinical trial. J Clin Periodontol. 2008;35:58–63.
Ungvári K, Pelsöczi IK, Kormos B, et al. Effects on titanium implant surfaces of chemical agents used for the treatment of peri-implantitis. J Biomed Mater Res B Appl Biomater. 2010;94:222–9.
Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol. 2008;35 Suppl 8:316–32.
Maness PC, Smolinski S, Blake DM, et al. Bactericidal activity of photocatalytic TiO(2) reaction: toward an understanding of its killing mechanism. Appl Environ Microbiol. 1999;65:4094–8.
Tsuang YH, Sun JS, Huang YC, et al. Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs. 2008;32:167–74.
Necula BS, Fratila-Apachitei LE, Zaat SA, et al. In vitro antibacterial activity of porous TiO2-Ag composite layers against methicillin-resistant Staphylococcus aureus. Acta Biomater. 2009;5:3573–80.
Liao J, Anchun M, Zhu Z, Quan Y. Antibacterial titanium plate deposited by silver nanoparticles exhibits cell compatibility. Int J Nanomedicine. 2010;5:337–42.
Rupp F, Haupt M, Klostermann H, Kim HS et al. Multifunctional nature of UV-irradiated nanocrystalline anatase thin films for biomedical applications. Acta Biomater. 2010 [Epub ahead of print]
Yoshinari M, Kato T, Matsuzaka K, et al. Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides. Biofouling. 2010;26:103–10.
Brohede U, Forsgren J, Roos S, et al. Multifunctional implant coatings providing possibilities for fast antibiotics loading with subsequent slow release. J Mater Sci Mater Med. 2009;20:1859–67.
Jiang B, Li B. Polypeptide nanocoatings for preventing dental and orthopaedic device-associated infection: pH-induced antibiotic capture, release, and antibiotic efficacy. J Biomed Mater Res B Appl Biomater. 2009;88:332–8.
Li H, Ogle H, Jiang B, Hagar M, Li B. Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: a preliminary study on cell responses. J Orthop Res. 2010;28:992–9.
O’Sullivan C, O’Hare P, O’Leary ND, et al. Deposition of substituted apatites with anticolonizing properties onto titanium surfaces using a novel blasting process. J Biomed Mater Res B Appl Biomater. 2010;95:141–9.
Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis. J Periodontol. 2010;81:15–23.
Boente RF, Ferreira LQ, Falcão LS, et al. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Anaerobe. 2010;16:190–4.
Perreten V, Kadlec K, Schwarz S, et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother. 2010;65:1145–55.
Kenawya ER, Bowlin GL, Kevin Mansfield K, et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Rel. 2002;81:57–64.
Rodrigues RM, Gonçalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol. 2004;31:420–7.
Schenk G, Flemmig TF, Betz T, et al. Controlled local delivery of tetracycline HCl in the treatment of periimplant mucosal hyperplasia and mucositis. A controlled case series. Clin Oral Implants Res. 1997;8:427–33.
Mombelli A, Feloutzis A, Brägger U, Lang NP. Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results. Clin Oral Implants Res. 2001;12:287–94.
Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B Appl Biomater. 2004;15:240–9.
Dashti A, Ready D, Salih V, et al. In vitro antibacterial efficacy of tetracycline hydrochloride adsorbed onto Bio-Oss bone graft. J Biomed Mater Res B Appl Biomater. 2010;93: 394–400.
Philippart P, Brasseur M, Hoyaux D. Human recombinant tissue factor, platelet-rich plasma, and tetracycilne induce a high-quality human bone graft: a 5-year survey. Int J Oral Maxillofac Impl. 2003;18:411–6.
Salvi GE, Mombelli A, Mayfield L, et al. Local antimicrobial therapy after initial periodontal treatment. J Clin Periodontol. 2002;29:540–50.
Bogren A, Teles RP, Torresyap G, et al. Locally delivered doxycycline during supportive periodontal therapy: a 3-year study. J Periodontol. 2008;79:827–35.
Büchter A, Meyer U, Kruse-Lösler B, Joos U, Kleinheinz J. Sustained release of doxycycline for the treatment of peri-implantitis: randomised controlled trial. Br J Oral Maxillofac Surg. 2004;42:439–44.
Büchter A, Kleinheinz J, Meyer U, Joos U. Treatment of severe peri-implant bone loss using autogenous bone and a bioabsorbable polymer that delivered doxycycline (Atridox). Br J Oral Maxillofac Surg. 2004;42:454–6.
Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol. 2001;72:1535–44.
Renvert S, Lessem J, Dahlén G, et al. Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. J Clin Periodontol. 2006;33:362–9.
Persson GR, Salvi GE, Heitz-Mayfield LJ, et al. Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of peri-implantitis. I: Microbiological outcomes. Clin Oral Implants Res. 2006;17:386–93.
Salvi GE, Persson GR, Heitz-Mayfield LJ, et al. Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: clinical and radiographic outcomes. Clin Oral Implants Res. 2007;18:281–5.
Stellini E, Migliorato A, Mazzoleni S, et al. Topical treatment of peri-implantitis with metronidazole dental gel 25%. Clinical analysis and microbiological control. Minerva Stomatol. 2000;49:59–67.
Flemmig TF, Gregor Petersilka G, Völp A, et al. Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. J Periodontol. 2011;82:96–105.
Sela MN, Babitski E, Steinberg D, et al. Degradation of collagen-guided tissue regeneration membranes by proteolytic enzymes of Porphyromonas gingivalis and its inhibition by antibacterial agents. Clin Oral Implants Res. 2009;20:496–502.
Mizrak T, Güncü GN, Caglayan F, et al. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters and prostaglandin E2 levels in gingival crevicular fluid. J Periodontol. 2006;77:437–43.
Porras R, Anderson GB, Caffesse R, et al. Clinical response to 2 different therapeutic regimens to treat peri-implant mucositis. J Periodontol. 2002;73:1118–25.
Christenson EM, Anseth KS, van den Beucken JJ, et al. Nanobiomaterial applications in orthopedics. J Orthop Res. 2007;25:11–22.
Duarte Fde F, Lotufo RF, Pannuti CM. Local delivery of chlorhexidine gluconate in patients with aggressive periodontitis. J Int Acad Periodontol. 2008;10:31–5.
Emrani J, Chee W, Slots J. Bacterial colonization of oral implants from nondental sources. Clin Implant Dent Relat Res. 2009;11:106–12.
Flores CY, Diaz C, Rubert A, Benítez GA, Moreno MS, Fernández Lorenzo deMele MA. Spontaneous adsorption of silver nanoparticles on Ti/TiO2 surfaces. Antibacterial effect on Pseudomonas aeruginosa. J Colloid Interface Sci. 2010;350:402–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Autogenous bonegraft
-
Involves utilizing bone obtained from the same individual receiving the graft
- Bactericidal
-
A substance that kills bacteria
- Bacteriostatic
-
A substance that inhibit growth and reproduction of bacteria without killing them
- Biofilm
-
A biofilm is an aggregate of microorganisms in which cells adhere to each other and/or to a surface
- Gingivitis
-
A reversible inflammation of the soft tissue surrounding the teeth
- Implant Mucositis
-
An inflammatory lesion that resides in the mucosa. This is clinically identified by redness, swelling, and bleeding on probing
- Nanotechnology
-
Nanotechnology deals with structures sized between 1 and 100 nm in at least one dimension and involves developing materials or devices within that size
- Osseo-integration
-
A direct structural and functional connection between living bone and the surface of a load-bearing artificial implant
- Peri-implantitis
-
An inflammatory lesion in the mucosa also affecting the supporting bone. This is clinically identified by redness, swelling bleeding on probing and bone loss
- Periodontitis
-
An irreversible inflammation of the soft and hard tissues surrounding the teeth leading to a loss of bone support
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Renvert, S., Persson, G.R. (2013). Topical Antimicrobial-Containing Biomaterials for Peri-Implant Infections in the Oral Cavity. In: Moriarty, T., Zaat, S., Busscher, H. (eds) Biomaterials Associated Infection. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1031-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1031-7_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1030-0
Online ISBN: 978-1-4614-1031-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)